The Pharmaletter

One To Watch

cellphire_company

Cellphire Therapeutics

"Cellphire, Inc. is a clinical-stage biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products."

"Its lead product is Thrombosomes, a freeze-dried hemostatic derived from human platelets. Cellphire's technology has potential applications across a wide range of medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine."

Want to Update your Company's Profile?


More Cellphire Therapeutics news >